Christine S. Rollier

University of Surrey — United Kingdom

Immunology and Microbiology · Life Sciences

32h-index13.3kcitations100works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bacterial Infections and Vaccines(22), Pneumonia and Respiratory Infections(15), Viral gastroenteritis research and epidemiology(15), Hepatitis B Virus Studies(14), SARS-CoV-2 and COVID-19 Research(11)

Publications90 total

Efficacy of a novel antigen-decorated adenoviral vaccine platform against porcine respiratory coronavirus infection in a large natural host
2025Open Access
The impact of the COVID-19 pandemic on healthy volunteer motivations: a mixed-methods study of participants in plague vaccine trials in the UK and Uganda
2025Open Access
Adenoviral-vectored vaccine against Bordetella pertussis fimbrial antigen induces partial protection in a mouse model
Vaccine X·2025Open Access
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine
Science Translational Medicine·2025· 2 cited
Porcine respiratory coronavirus as a model for acute respiratory disease: mechanisms of different infection outcomes
The Journal of Immunology·2025· 1 citedOpen Access
Contributors
Elsevier eBooks·2025
Adenoviral vaccines—Infectious disease
Elsevier eBooks·2025
Approaches to Enhance the Potency of Vaccines in Chickens
Vaccines·2024· 6 citedOpen Access
Pathogenesis and immune response to respiratory coronaviruses in their natural porcine host
2024Open Access
Approaches to Enhance the Potency of Poultry Vaccines
Preprints.org·2024· 2 citedOpen Access
DNA Vaccines: History, Molecular Mechanisms and Future Perspectives
Journal of Molecular Biology·2023· 72 citedOpen Access
Immune responses to Neisseria gonorrhoeae and implications for vaccine development
Frontiers in Immunology·2023· 31 citedOpen Access
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease
Science Translational Medicine·2023· 5 citedOpen Access
Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines
Vaccine·2023· 5 citedOpen Access
Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
Clinical & Experimental Immunology·2023· 2 citedOpen Access
Regulatory T cell profiles in patients with N-methyl-ᴅ-aspartate receptor-antibody encephalitis
encephalitis·2023· 5 citedOpen Access
Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus
Cell & Bioscience·2022· 3 citedOpen Access
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation
Vaccine·2022· 6 citedOpen Access
Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial
Vaccine·2022· 7 citedOpen Access
Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity
Frontiers in Immunology·2022· 27 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Andrew J. Pollard(17), Adrian V. S. Hill(14), Christina Dold(13), David Wyllie(10), Arturo Reyes‐Sandoval(8), Jonathan L. Heeney(8), Babs E. Verstrepen(8), Sarah C. Gilbert(6), Alexandra J. Spencer(6), Joost Drexhage(6), Ernst J. Verschoor(6), Manish Sadarangani(6), Amy Flaxman(5), Lucyna Cova(5), Leanne Marsay(5), Katie Ewer(4), Miles W. Carroll(4), Teresa Lambe(4), Elizabeth Allen(4), Matthew G. Cottingham(4)